Pathstone Family Office’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$169K Buy
+20,500
New +$177K ﹤0.01% 1547
2021
Q1
Sell
-500
Closed -$10K 732
2020
Q4
$10K Hold
500
﹤0.01% 870
2020
Q3
$8K Hold
500
﹤0.01% 626
2020
Q2
$9K Hold
500
﹤0.01% 529
2020
Q1
$8K Buy
+500
New +$12.1K ﹤0.01% 561
2019
Q4
Sell
-500
Closed -$11K 437
2019
Q3
$11K Hold
500
﹤0.01% 469
2019
Q2
$13K Hold
500
﹤0.01% 490
2019
Q1
$12K Buy
+500
New +$11.9K ﹤0.01% 483

Other funds holding BHC

Pathstone Family Office's BHC Position: Q3 2023 in Review

Pathstone Family Office opened a new position in Bausch Health (BHC) in Q3 2023: 20,500 shares worth $169K. The stake represents ﹤0.01% of the portfolio and ranks #1547 among its holdings. This is a return to the name: Pathstone Family Office previously reported a position in BHC as recently as Q4 2020.

Pathstone Family Office first reported a position in BHC in Q1 2019 and has held it in 8 quarters since. 223 funds tracked by Wall St. Rank hold BHC as of Q3 2023.

  • Pathstone Family Office held 20,500 shares of Bausch Health worth $169K as of Q3 2023.
  • Bausch Health was a new Pathstone Family Office position in Q3 2023.
  • Bausch Health made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1547 holding.
  • Pathstone Family Office first reported a position in Bausch Health in Q1 2019 and has held it in 8 quarters since.
  • 223 funds tracked by Wall St. Rank held Bausch Health as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.